Home › Funds › ORBIMED ADVISORS LLC › SYK
ORBIMED ADVISORS LLC position in SYK
STRYKER CORPORATION · Health Care
ORBIMED ADVISORS LLC reported holding 159,100 shares of SYK (STRYKER CORPORATION) in its Q2 2026 13F filing — a position valued at US$50.1M, representing 1.01% of its reported portfolio and ranking #31 among its reported holdings. ORBIMED ADVISORS LLC has disclosed SYK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ORBIMED ADVISORS LLC's SYK position evolved
ORBIMED ADVISORS LLC first disclosed a stake in SYK in Q3 2023 at 269,000 shares (US$73.5M). The position peaked in Q2 2025 at 359,200 shares, worth US$142.1M. Across 12 filings, ORBIMED ADVISORS LLC increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 159,100 shares valued at US$50.1M — a reduction of -23,400 shares quarter over quarter.. Notable position changes include a 28% increase in Q3 2024 (shares were roughly flat over the following quarter), a 44% trim in Q1 2026 (shares fell 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 269.00K | $73.51M | New |
| Q4 2023 | 269.00K | $80.55M | Hold |
| Q1 2024 | 269.00K | $96.27M | Hold |
| Q2 2024 | 269.00K | $91.53M | Hold |
| Q3 2024 | 344.40K | $124.42M | Add |
| Q4 2024 | 344.40K | $124.00M | Hold |
| Q1 2025 | 359.20K | $133.71M | Add |
| Q2 2025 | 359.20K | $142.11M | Hold |
| Q3 2025 | 359.20K | $132.79M | Hold |
| Q4 2025 | 325.00K | $114.23M | Reduce |
| Q1 2026 | 182.50K | $59.97M | Reduce |
| Q2 2026 | 159.10K | $50.09M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SYK and 13F data
SYK (STRYKER CORPORATION) is a Health Care company. 25 other funds we track also report a position in SYK — the largest reported positions include JPMorgan Chase & Co (US$5.71B), GREENLEAF TRUST (US$4.79B), PRICE T ROWE ASSOCIATES INC /MD/ (US$3.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SYK
- JPMorgan Chase & Co 17.26M sh · $5.71B · Q2 2026
- GREENLEAF TRUST 15.23M sh · $4.79B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 11.92M sh · $3.75B · Q2 2026
- Wellington Management Group 8.17M sh · $2.57B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 8.17M sh · $2.57B · Q2 2026
- ALLIANCEBERNSTEIN L.P. 4.93M sh · $1.62B · Q2 2026
- Arrowstreet Capital 3.28M sh · $1.03B · Q2 2026
- First Western Trust Bank 3.02M sh · $949.98M · Q2 2026
- Fundsmith LLP 2.91M sh · $917.39M · Q2 2026
More on ORBIMED ADVISORS LLC
FAQ
How long has ORBIMED ADVISORS LLC held SYK?
ORBIMED ADVISORS LLC has disclosed SYK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is ORBIMED ADVISORS LLC's current position in SYK?
As of Q2 2026, ORBIMED ADVISORS LLC holds 159.10K shares of SYK (STRYKER CORPORATION), valued at $50.09M, representing 1.01% of its reported portfolio and ranking #31.
Has ORBIMED ADVISORS LLC been buying or selling SYK?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC reduced its position in SYK. The position peaked in Q2 2025 at 359.20K shares.
Which other funds hold SYK?
Other major institutional holders of SYK include JPMorgan Chase & Co, GREENLEAF TRUST, PRICE T ROWE ASSOCIATES INC /MD/, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.